Thu, September 22, 2022
Wed, September 21, 2022
Tue, September 20, 2022

Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $28 on, Sep 21st, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-28-on-sep-21st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $23 to $28 on, Sep 21st, 2022.

Ryan has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Ryan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ryan


  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $23 on, Wednesday, August 10th, 2022